Excellent preliminary results among post-AMI patients included in the ATHENAS project
The Germans Trias Heart Institute (iCor) presented this Wednesday, November 19, the preliminary results achieved in the ATHENAS project , led by the Cardiology Service of the Germans Trias i Pujol University Hospital (HUGTiP) , and with the collaboration of the Endocrinology and Rehabilitation Service. The ATHENAS project ( ATHErosclerosis loweriNg As Soon as possible […]
The Arrhythmia Unit at Germans Trias incorporates pioneering technology in Catalonia for the treatment of cardiac arrhythmias
The Electrophysiology and Cardiac Arrhythmias Unit of the Heart Institute (iCor) of the Germans Trias i Pujol Hospital (HUGTiP) has successfully performed the first procedure in Catalonia with a state-of-the-art technology ablation system that combines, in a single catheter, the capacity for three-dimensional mapping and ablation using radiofrequency (heat) and electric field pulse energy ( […]
The first cardiac bioimplant developed to treat patients with myocardial infarction, the PeriCord
When a myocardial infarction occurs, blood stops circulating and properly nourishing the heart muscle cells. The heart loses strength to beat due to the death of cells in the injured area, which have stopped receiving blood from the coronary arteries. As a result of cell death, a permanent non-contractile scar is generated, which affects the […]
iCor – IGTP and Boehringer Ingelheim strengthen their collaboration with preclinical research
The biopharmaceutical company Boehringer Ingelheim has signed a new collaboration agreement with the Germans Trias i Pujol Research Institute (IGTP) to launch a new research project focused on evaluating the potential benefit of a new molecule in the cardiovascular-renal-metabolic axis. The alliance between both institutions is part of a strategic collaboration initiated in 2020 between […]
The first VASCRAFT bioimplant successfully applied
The consortium made up of the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and IQS Barcelona has successfully performed the first vascular graft of biological origin, known as VASCRAFT, as a therapeutic and innovative alternative for coronary bypass in patients with coronary disease. The VASCRAFT project, formed by a […]
